STOCK TITAN

Humana Stock Price, News & Analysis

HUM NYSE

Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.

Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.

Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.

Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.

Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.

Rhea-AI Summary

Humana Inc. (NYSE: HUM), in collaboration with The Humana Foundation and the University of Louisville, announced a $25 million investment in the Health Equity Innovation Hub. This initiative aims to enhance health equity for marginalized populations in Louisville and beyond. The funding includes $1.5 million from Humana and up to $13.5 million from The Humana Foundation, marking one of the largest donations in UofL’s history. The Hub will focus on research, talent development, and entrepreneurship, addressing social determinants of health to improve overall health outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none
-
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has received notification from the Louisiana Department of Health to award a contract for providing Medicaid coverage in Louisiana. The Medicaid division, Humana Healthy Horizons, plans to commence service later this year, contingent on completing the protest period. The initiative aims to enhance health outcomes for 1.6 million Medicaid beneficiaries in Louisiana through a holistic care approach. This selection underscores Humana's commitment to improving community health and supporting urgent needs through programs addressing social determinants of health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
none
-
Rhea-AI Summary

Humana Inc. (NYSE: HUM) announced that CEO Bruce D. Broussard will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 18, 2022, at 11:20 a.m. ET. Interested investors can access a live audio webcast on Humana’s Investor Relations page at humana.com. The company emphasizes its commitment to integrated healthcare, aiming to improve health and reduce costs for its members through various services, including in-home care and data analytics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Summary

Humana Specialty Pharmacy announced the addition of two oncology therapies: TAGRISSO® (osimertinib) for EGFRm non-small cell lung cancer and LENVIMA® (lenvatinib) for various cancers. These drugs will be delivered directly to patients, supported by Humana's Oncology Center of Excellence, which offers expert guidance on treatment. Humana is dedicated to enhancing patient experiences and health outcomes while managing chronic and complex illnesses through personalized services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Summary

Humana reported a 4Q21 loss per common share of $0.11 on a GAAP basis, while adjusted EPS stood at $1.24. For FY 2021, GAAP EPS was $22.67, down from $25.31 in FY 2020. The company anticipates FY 2022 GAAP EPS of at least $23.08 and adjusted EPS of at least $24.00, considering a $1.00 negative COVID-19 impact. Humana plans to create $1 billion in value through cost savings and productivity initiatives, focusing on its Medicare Advantage business and healthcare services expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has announced winners of its 2021 Go365 National Step Challenge, involving over 33,000 participants from various companies. Participants collectively logged 7.2 billion steps, leading to a donation of meals to local food banks, totaling an equivalent of one million meals. The challenge promotes health and community support, with winners from different divisions receiving donations in their names. The initiative has provided 4 million meals to Feeding America since its inception in 2018, addressing food insecurity while encouraging healthier lifestyles.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.07%
Tags
none
-
Rhea-AI Summary

Humana Inc. is set to expand its CenterWell Senior Primary Care network by opening 26 new centers in 2022, enhancing access for underserved seniors across the Dallas-Ft. Worth, Phoenix, Louisville, Nashville, and Charlotte markets. This expansion will mark CenterWell's entry into Arizona, Kentucky, and Tennessee. With approximately 200 existing centers across nine states, the organization aims to increase this number to between 240-260 by year-end, improving personalized healthcare for 300,000 Medicare patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
none
-
Rhea-AI Summary

Humana Inc. (NYSE: HUM) has appointed Dr. Andrew Agwunobi, a seasoned health care executive, as President of its Home Solutions business, effective February 21. Dr. Agwunobi previously served as interim President of the University of Connecticut and CEO of UConn Health. He has extensive experience in health care operations, including leadership roles in various health systems. His expertise in home health care aligns with Humana's vision to enhance at-home care services, particularly in the wake of increased demand during the COVID pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
none
Rhea-AI Summary

Humana Inc. (NYSE: HUM) will announce its fourth quarter 2021 financial results on February 2, 2022, at 6:30 a.m. Eastern time. A conference call to discuss the results and 2022 earnings guidance will occur at 9:00 a.m. Eastern time on the same day. Telephone participants must register in advance to receive call details. A webcast will also be available on Humana’s Investor Relations page. The earnings release is expected to include non-GAAP financial measures with detailed reconciliations provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags

FAQ

What is the current stock price of Humana (HUM)?

The current stock price of Humana (HUM) is $290.65 as of October 24, 2025.

What is the market cap of Humana (HUM)?

The market cap of Humana (HUM) is approximately 35.0B.
Humana

NYSE:HUM

HUM Rankings

HUM Stock Data

35.04B
119.97M
0.21%
96.12%
3.85%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
LOUISVILLE